ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial.

Mark A Exley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.